Epitomee Medical Financials
| EPIT Stock | 938.20 30.20 3.33% |
Epitomee |
Understanding current and past Epitomee Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Epitomee Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Epitomee Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Epitomee Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Epitomee Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Epitomee Medical's management manipulating its earnings.
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011825911 |
| Business Address | Tarshish Industrial Park |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.epitomeemedical.com |
Epitomee Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Epitomee Medical's current stock value. Our valuation model uses many indicators to compare Epitomee Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Epitomee Medical competition to find correlations between indicators driving Epitomee Medical's intrinsic value. More Info.Epitomee Medical is rated # 5 in current valuation category among its peers. It also is rated # 5 in shares outstanding category among its peers creating about 0.09 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Epitomee Medical is roughly 11.46 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Epitomee Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Epitomee Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Epitomee Medical Systematic Risk
Epitomee Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Epitomee Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Epitomee Medical correlated with the market. If Beta is less than 0 Epitomee Medical generally moves in the opposite direction as compared to the market. If Epitomee Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Epitomee Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Epitomee Medical is generally in the same direction as the market. If Beta > 1 Epitomee Medical moves generally in the same direction as, but more than the movement of the benchmark.
Epitomee Medical Thematic Clasifications
Epitomee Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Epitomee Medical November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Epitomee Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Epitomee Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Epitomee Medical based on widely used predictive technical indicators. In general, we focus on analyzing Epitomee Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Epitomee Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.65 | |||
| Information Ratio | 0.1133 | |||
| Maximum Drawdown | 273.98 | |||
| Value At Risk | (7.13) | |||
| Potential Upside | 23.06 |
Complementary Tools for Epitomee Stock analysis
When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |